EPCAM and breast carcinoma: Unfortunately, although the authors pointed out that EpCAM is overexpressed in breast cancer CSCs, they did not perform experiments, such as tumorsphere formation assays, to evaluate the inhibitory effects of EpCAM-AsiCs on CSCs.